Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|December 1, 2020
Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsKenneth Getz, Zachary Smith, Laura Shafner, et al.
Stroke|April 8, 2017
Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation TherapyDaniel L Labovitz, Laura Shafner, Morayma Reyes Gil, et al.
Open Forum Infectious Diseases|August 21, 2020
Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot StudyAlain H Litwin, Laura Shafner, Brianna Norton, et al.
JMIR Mhealth and Uhealth|February 23, 2017
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With SchizophreniaEarle E Bain, Laura Shafner, David P Walling, et al.
AIDS and Behavior|October 12, 2020
DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with MenAlbert Y Liu, Nicole D Laborde, Kenneth Coleman, et al.
Pageof 1